Experimental drug may reduce length, severity of attacks
pain crises
A Sickle Cell Milestone
New drug with OMRF roots reduces pain in sickle cell disease.
FDA approves new sickle cell drug with Oklahoma roots
Adakveo significantly reduces pain crises in sickle cell patients.
